Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine vs Lamivudine in HBeAg-negative Chronic Hepatitis B
NCT01005238Phase 4Terminated
- Sponsor
- University Hospital Basel
- Start
- Sep 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine in Chronic Hepatitis B (CHB), sponsored by University Hospital Basel. Started Sep 2009; status: terminated.
02
Drugs
lamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01005238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005238.